Current Vaccine News and Events

Current Vaccine News and Events, Vaccine News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
University of Minnesota researchers develop two new rapid COVID-19 diagnostic tests
University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms. (2021-02-23)

Biological therapy has proved a suitable alternative to antibiotics
Tel Aviv University researchers have developed a biological substitute for the treatment of tuberculosis, which in the future could serve as an alternative for the traditional ''chemical'' antibiotic therapy. Dr. Freund: ''Advances in molecular medicine enable us to develop new tools to rout microbes, which can also solve the problem of drug-resistant germs''. This groundbreaking study has been published in the prestigious scientific journal Nature Communications. (2021-02-22)

Researchers learn that pregnant women pass along protective COVID antibodies to their babies
Antibodies that guard against COVID-19 can transfer from mothers to babies while in the womb, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers published in the American Journal of Obstetrics and Gynecology. (2021-02-22)

CovMT: Tracking virus mutations across the world
An interactive platform helps users visualize where SARS-CoV-2 mutations start, how wide they spread and how infectious they are. (2021-02-21)

New study highlights lack of diversity and inclusion in vaccine clinical trials
A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities. (2021-02-19)

Including racial/ethnic minorities, females, older adults in vaccine trials
Using data from completed interventional vaccine trials from 2011 to 2020, researchers examined whether racial/ethnic minority groups, females and older adults were underrepresented in U.S.-based vaccine clinical trials. (2021-02-19)

New review compiles immunogenicity data on leading SARS-CoV-2 vaccine candidates
In a new Review, P.J. Klasse and colleagues present an extensive overview of the immunogenicity profiles of several leading SARS-CoV-2 vaccine candidates, including several developed under the auspices of (2021-02-19)

The Lancet: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
* Exploratory analyses including 17,178 participants find that higher vaccine efficacy is obtained with a longer interval between the first and second standard dose (81% for 3-month interval vs 55% for up to 6-week interval). In addition, a single dose of vaccine is highly efficacious in the first 3 months (76% efficacy from 22 days after vaccination onwards). (2021-02-19)

'Classic triad' of symptoms misses positive COVID-19 cases, study finds
Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease. (2021-02-18)

The Lancet Healthy Longevity: Study finds racial and ethnic disparities in flu vaccine uptake among people aged 65 and older in the USA
A new study published today in The Lancet Healthy Longevity journal has found significant racial and ethnic disparities in uptake of the seasonal influenza vaccine among people aged 65 years and over in the USA. (2021-02-18)

It's morally wrong for rich nations to hoard COVID-19 vaccine
Rich nations should not engage in ''vaccine nationalism'' and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York. Hassoun's paper, ''Against Vaccine Nationalism,'' was published in the Journal of Medical Ethics. (2021-02-16)

COVID-19 infection rates high in pregnant women
The study also showed that the number of COVID-19 infections in pregnant patients from nearly all communities of color in Washington was high. There was a twofold to fourfold higher prevalence of pregnant patients with COVID-19 infections from communities of color than expected based on the race-ethnicity distribution of pregnant women in Washington in 2018. (2021-02-16)

NIH experts discuss SARS-CoV-2 viral variants
The rise of significant variants of SARS-CoV-2 has attracted the attention of health and science experts worldwide. In an editorial published in JAMA, experts from the National Institute of Allergy and Infectious Diseases outline how these variants have arisen, concerns about whether vaccines currently authorized for use will continue to protect against new variants, and the need for a global approach to fighting SARS-CoV-2 as it spreads and acquires additional mutations. (2021-02-12)

ACC urges COVID-19 vaccine prioritization for highest risk heart disease patients
COVID-19 vaccine prioritization should prioritize those with advanced cardiovascular (CVD) disease over well-managed CVD disease, according to an American College of Cardiology (ACC) health policy statement published in the Journal of the American College of Cardiology (JACC). (2021-02-12)

The Lancet: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout
Having new COVID-19 vaccines will mean little if people around the world are unable to get vaccinated in a timely manner. Vaccines have to be affordable and available to all countries, and governments must have the administrative and political capacities to deliver them locally to ensure an effective global immunisation strategy against COVID-19, say the authors of a Health Policy piece published in The Lancet. (2021-02-12)

New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recomm
The Advisory Committee on Immunization Practices (ACIP) has released its 2021 Recommended Adult Immunization Schedule that includes changes to several vaccines including influenza, hepatitis A, human papillomavirus (HPV); and the measles, mumps and rubella (MMR) vaccine. The schedule also includes interim recommendations for COVID-19 vaccination. The complete schedule, including changes in the vaccine notes section, is being simultaneously published in Annals of Internal Medicine and on the Centers for Disease Control and Prevention (CDC) web site. (2021-02-11)

One dose of COVID-19 vaccine provokes strong immune response in those previously infected
Researchers report preliminary evidence that people previously infected with COVID-19 responded very strongly to one dose of the Pfizer vaccine, regardless of when they were infected and whether or not they had detectable antibodies against COVID-19 prior to receiving the vaccine. The response was so effective that it opens the debate as to whether one dose of the vaccine may suffice. The research also provided evidence that immune response was similar across multi-ethnic groups. (2021-02-11)

Study predicts UK COVID-19 vaccination program will very quickly reduce deaths but more slowly bring down hospital and ICU admissions
A new modelling study published in Anaesthesia (a journal of the Association of Anaesthetists) shows that the UK's coronavirus vaccination program is already reducing daily deaths. However, reductions of hospital and intensive care (ICU) admissions will likely take several weeks longer, with large reductions seen by the end of March and continuing into April. (2021-02-11)

Study finds U.S. first responders have mixed feelings about COVID-19 vaccine
Firefighters and emergency medical services workers are at high risk of exposure to COVID-19 while on the job and pose an additional risk of transmitting the virus to others. Although vaccines are a promising public health tool for reducing COVID-19 transmission, little has been known about the perceptions of the COVID-19 vaccine among first responders. (2021-02-10)

Caution: 1918 influenza provides warning for potential future pandemic reemergence
New research from Michigan State University used health data from the initial 1918 influenza spike to provide insights to what ''pandemic reemergence'' may look like for our future. (2021-02-10)

Experts' top COVID mitigation action: Nat'l stay at home order with financial compensation
A report summary released today by a team at Lehigh University led by Thomas McAndrew, a computational scientist and assistant professor in Lehigh's College of Health, shares the consensus results of experts in the modeling of infectious disease when asked to rank the top 5 most effective interventions to mitigate the spread and impact of COVID-19 in the US. (2021-02-10)

Vaccine confidence grows under new administration, latest CUNY SPH Survey reveals
Under the Biden Administration, New Yorkers' acceptance of the Covid-19 vaccine has increased significantly. In September, 55% of residents reported they would take the vaccine when it became available and this January, 64% reported they would take it. (2021-02-09)

Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
In an article that appears in the journal Nature, Dennis Burton, PhD, and Eric Topol, MD, of Scripps Research call for governments to provide significant funding support for rational vaccine design based on broadly neutralizing antibodies. Such antibodies provide broad-spectrum potency against viruses, a valuable characteristic that opens the door to vaccines that could provide immunity against the many variants that might evolve from a fast-mutating virus. They could also be used as drugs to prevent and treat infections. (2021-02-09)

History of vaccines offers lessons on COVID-19 for pregnant women
DALLAS - Feb. 8, 2021 - Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obstetricians published today in JAMA. That guidance can take lessons from what is already known about other vaccines given during pregnancy. (2021-02-08)

Higher excess COVID-19 death risk in middle-aged people with type 2 diabetes
A largescale analysis led by the University of Exeter and funded by Diabetes UK, has found a disproportionately higher COVID-19 death risk in middle-aged people with type 2 diabetes, raising questions over vaccination strategies across Europe. (2021-02-08)

New AI tool can thwart coronavirus mutations
USC computer scientists used AI to create a new tool that rapidly identifies potential solutions to coronavirus mutations and screens vaccines much faster to give humans an advantage over the contagion. (2021-02-05)

The Lancet Public Health: Survey taken after France's first COVID-19 wave indicates almost one-third of working-age people could reject a vaccine
Nearly one in three working-age adults in France (29%) surveyed in July 2020 - when lockdown restrictions had been eased - were outright opposed to being vaccinated against the virus, according to new research published in The Lancet Public Health journal. (2021-02-05)

City, University of London academic tracks COVID-19 dark web marketplaces
New research carried out by Dr Andrea Baronchelli and his colleagues into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines. (2021-02-04)

Study shows flu vaccine lessens COVID-19 symptoms in children
Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection. The finding comes from a review of more than 900 children diagnosed with COVID-19 in 2020. (2021-02-04)

COVID-19 vaccine from new vaccine platform effective in mice
It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically. Researchers at Karolinska Institutet in Sweden now report that they have developed a prototype vaccine against SARS-CoV-2 using a DNA vaccine platform that is inexpensive, stable, easy to produce, and shows a good safety profile. A study published in Scientific Reports shows that the vaccine induces potent immune responses in mice. (2021-02-04)

Emory MVA COVID-19 vaccine safe and effective in animal models
Yerkes NPRC/Emory University researchers have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys. The Emory MVA COVID-19 vaccine uses modified vaccinia Ankara (MVA) to induce strong neutralizing antibodies and killer CD8 T cells. Researchers say the vaccine is easily adaptable to address variants, can be used in combination with existing vaccines to improve their ability to combat variants and may be equally effective with a single dose. (2021-02-04)

City, University of London academic tracks COVID-19 dark web marketplace before vaccine
Dr Andrea Baronchelli, and colleagues have carried out insightful research into the dark web marketplace (DWM) trade in products related to COVID-19; they have revealed the need for the continuous monitoring of dark web marketplaces (DWMs) especially in light of the current shortage and availability of coronavirus vaccines. (2021-02-04)

Unusual 2019-2020 flu season linked to more transmissible strain
The 2019-2020 flu season in the U.S. was unusual in a number of ways. Cases picked up in August rather than the more typical fall and early winter months, and it hit children particularly hard. (2021-02-04)

Duration of antibody response varies among adults naturally reinfected with RSV
Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made the individuals susceptible to RSV reinfection. (2021-02-04)

Experimental vaccine blunts the deadliest of synthetic opioids
As the opioid epidemic raged on with an even greater force during COVID-19, the Scripps Research laboratory of chemist Kim Janda, PhD, has been working on new therapeutic interventions that may be able to prevent the bulk of deaths from opioid overdose. Janda and his team have developed experimental vaccines that have shown in rodents to blunt the deadly effects of fentanyl as well as its even more fatal cousin, carfentanil. (2021-02-04)

More than half of cancer survivors have underlying medical conditions associated with severe COVID
New study finds more than half (56.4%) of cancer survivors in the United States reported having additional underlying medical conditions associated with severe COVID-19 illness. (2021-02-03)

COVID-19 vaccination for patients with Parkinson's disease recommended
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in the Journal of Parkinson's Disease, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication. (2021-02-03)

Intranasal influenza vaccine spurs strong immune response in Phase 1 study
An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation. The investigational vaccine, called Ad4-H5-VTN, is a recombinant, replicating adenovirus vaccine designed to spur antibodies to hemagglutinin, a protein found on the surface of influenza viruses that attaches to human cells. (2021-02-03)

First-in-human clinical trial confirms HIV vaccine approach by IAVI and Scripps Research
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus; the targeted response was detected in 97 percent of participants who received the vaccine. (2021-02-03)

Engineering immunity
University of New Mexico researchers study the use of virus-like particles to create a stable and effective malaria vaccine. (2021-02-03)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.